ContraFect Announces 7.03M Share Offering by Selling Stockholders
- ByInvesting.com-
ContraFect (NASDAQ:CFRX) has filed for up to 7,034,883 share offering by selling stockholders.
Symbol | Exchange | Currency |
|---|
ContraFect (NASDAQ:CFRX) has filed for up to 7,034,883 share offering by selling stockholders.
ContraFect (NASDAQ:CFRX) Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins...
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York.
| Average | 190.000 (+12,566.667% Upside) |
| High | 560.000 |
| Low | 3.000 |
| Price | 1.500 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Sell | Sell | Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Sell | Strong Sell | Strong Sell |
| Summary | Sell | Strong Sell | Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.32 | 1.555 | 1.00 | -1.230 | -48.24% | 58.84M | NASDAQ | |||
| 91.22 | 93.48 | 90.00 | +1.43 | +1.59% | 2.14M | NASDAQ | |||
| 0.01 | 0.01 | 0.01 | 0.00 | +1.72% | 49.53K | OTC Markets | |||
| 2.35 | 2.50 | 2.30 | -0.1400 | -5.62% | 49.73K | NASDAQ | |||
| 14.46 | 14.76 | 14.07 | +0.17 | +1.19% | 963.46K | NASDAQ | |||
| 92.16 | 92.51 | 91.02 | +1.16 | +1.27% | 12.00M | NYSE | |||
| 54.08 | 54.94 | 50.25 | 0.00 | 0.00% | 0.00 | NYSE | |||
| 68.02 | 68.99 | 65.72 | +2.36 | +3.59% | 4.00M | NYSE | |||
| 354.13 | 356.34 | 344.00 | +9.99 | +2.90% | 204.37K | NYSE | |||
| 3.68 | 3.85 | 3.37 | +0.24 | +7.13% | 5.17M | NASDAQ | |||
| 7.88 | 7.88 | 7.30 | +0.21 | +2.74% | 78.52M | NYSE | |||
| 0.15 | 0.15 | 0.15 | 0.00 | 0.00% | 0.00 | NASDAQ | |||
| 65.98 | 66.18 | 62.21 | +2.44 | +3.84% | 10.38M | NYSE | |||
| 0.291 | 0.315 | 0.287 | +0.002 | +0.52% | 141.37K | NASDAQ | |||
| 59.97 | 59.99 | 59.97 | 0.00 | 0.00% | 0.00 | NASDAQ |